MedShadow rounds up FDA recalls at three compounders, including Carolina Infusion and Apothecary Pharma, plus inspection findings on sterile processing.
Recap by typeshit. Full story at MedShadow Foundation.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
STAT
STAT, citing the AP, notes the peptides involved aren't FDA approved as safe or effective and most of their data comes from animal studies.
Novo's head of diabetes marketing discusses how the company is reaching patients and what it learned from the Wegovy pill rollout.
Loading…